Skip to main content
Top
Published in: Rheumatology International 10/2008

01-08-2008 | Case Report

A case of adult onset Still’s disease showing marked accumulation in the liver and spleen, on positron emission tomography–CT images

Authors: Masanori Funauchi, Shinya Ikoma, Kazuya Kishimoto, Hideki Shimazu, Yuji Nozaki, Masafumi Sugiyama, Koji Kinoshita

Published in: Rheumatology International | Issue 10/2008

Login to get access

Abstract

A 35-year-old woman was admitted to our hospital because of high fever and skin rash, and subsequently diagnosed as having adult onset Still’s disease (AOSD). Because of resistance to the steroid hormones, high levels of the serum-soluble form of the interleukin-2 receptor and splenomegaly, we suspected a possible diagnosis of malignant lymphoma and performed positron emission tomography (PET), which disclosed an intense accumulation of 2-deoxy-2 [F18] fluoro-d-glucose (FDG) in the liver and spleen. However, bone marrow aspiration and liver biopsy did not reveal any malignant cells. After the treatment of high-dose adrenocorticosteroids and plasma exchange, her symptoms and laboratory data, including PET findings, gradually improved. This is a rare case of severe AOSD in which an intense accumulation of FDG was detected by PET, and a differential diagnosis from malignant lymphoma may be difficult by FDG-PET alone, so that careful evaluation by techniques including histopathological examination may be necessary.
Literature
1.
go back to reference Kennedy C, Des Rosiers MH, Jehle JW, Reivich M, Sharpe F, Sokoloff L (1975) Mapping of functional neural pathways by autoradiographic survey of local metabolic rate with (14C) deoxyglucose. Science 187:850–853PubMedCrossRef Kennedy C, Des Rosiers MH, Jehle JW, Reivich M, Sharpe F, Sokoloff L (1975) Mapping of functional neural pathways by autoradiographic survey of local metabolic rate with (14C) deoxyglucose. Science 187:850–853PubMedCrossRef
2.
go back to reference Som P, Atkins HL, Bandoypadhyay D et al (1980) A fluorinated glucose analog, 2-fluoro-2-deoxy-d-glucose (F-18): nontoxic tracer for rapid tumor detection. J Nucl Med 21:670–675PubMed Som P, Atkins HL, Bandoypadhyay D et al (1980) A fluorinated glucose analog, 2-fluoro-2-deoxy-d-glucose (F-18): nontoxic tracer for rapid tumor detection. J Nucl Med 21:670–675PubMed
3.
go back to reference Kubota R, Yamada S, Kubota K (1992) Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 33:1972PubMed Kubota R, Yamada S, Kubota K (1992) Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 33:1972PubMed
4.
go back to reference Blockmans D, de Ceuninck L, Vandershueren S, Knockaert D, Mortelmans L, Bobbaers H (2006) Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients. Arthritis Rheum 55:131–137PubMedCrossRef Blockmans D, de Ceuninck L, Vandershueren S, Knockaert D, Mortelmans L, Bobbaers H (2006) Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients. Arthritis Rheum 55:131–137PubMedCrossRef
5.
go back to reference Gupta P, Ponzo F, Kramer EL (2005) Fluorodeoxyglucose (FDG) uptake in pulmonary rheumatoid nodules. Clin Rheumatol 24:402–405PubMedCrossRef Gupta P, Ponzo F, Kramer EL (2005) Fluorodeoxyglucose (FDG) uptake in pulmonary rheumatoid nodules. Clin Rheumatol 24:402–405PubMedCrossRef
6.
go back to reference Moreno D, Yuste JR, Rodriguez M, García-Velloso MJ, Prieto J (2005) Positron emission tomography use in the diagnosis and follow up of Takayasu’s arteritis. Ann Rheum Dis 64:1091–1093PubMedCrossRef Moreno D, Yuste JR, Rodriguez M, García-Velloso MJ, Prieto J (2005) Positron emission tomography use in the diagnosis and follow up of Takayasu’s arteritis. Ann Rheum Dis 64:1091–1093PubMedCrossRef
7.
go back to reference Hashimoto M, Shingu M, Ezaki I, Yoshikawa Y, Nobunaga M 1995 Clinical studies on 14 cases of adult-onset Still’s disease. Nihon Rinsho Meneki Gakkai Kaishi 18:45–52PubMed Hashimoto M, Shingu M, Ezaki I, Yoshikawa Y, Nobunaga M 1995 Clinical studies on 14 cases of adult-onset Still’s disease. Nihon Rinsho Meneki Gakkai Kaishi 18:45–52PubMed
8.
go back to reference Goumri S, El Kabli H, Alaoui FZ, Bettal S, Benamour S (2006) Adult-onset Still disease. 11 cases. Tunis Med 84:443–449 (in French)PubMed Goumri S, El Kabli H, Alaoui FZ, Bettal S, Benamour S (2006) Adult-onset Still disease. 11 cases. Tunis Med 84:443–449 (in French)PubMed
9.
go back to reference Uppal SS, Al-Mutairi M, Hayat S, Abraham M, Malaviya A (2007) Ten years of clinical experience with adult onset Still’s disease: is the outcome improving? Clin Rheumatol 26:1055–1060PubMedCrossRef Uppal SS, Al-Mutairi M, Hayat S, Abraham M, Malaviya A (2007) Ten years of clinical experience with adult onset Still’s disease: is the outcome improving? Clin Rheumatol 26:1055–1060PubMedCrossRef
10.
go back to reference Ben Taarit C, Turki S, Ben Maïz H (2002) Adult Still’s disease: study of a series of 11 cases. J Mal Vasc 27:31–35PubMed Ben Taarit C, Turki S, Ben Maïz H (2002) Adult Still’s disease: study of a series of 11 cases. J Mal Vasc 27:31–35PubMed
11.
go back to reference Wouters JM, van de Putte LB (1986) Adult-onset Still’s disease; clinical and laboratory features, treatment and progress of 45 cases. Q J Med 61:1055–1065PubMed Wouters JM, van de Putte LB (1986) Adult-onset Still’s disease; clinical and laboratory features, treatment and progress of 45 cases. Q J Med 61:1055–1065PubMed
12.
go back to reference Linde B, Oelzner P, Katenkamp K, Hein G, Wolf G (2007) Fulminate liver failure in a 39-year-old female patient with leukocytosis, unclear fever, and arthralgic pain. Med Klin (Munich) 102:846–851CrossRef Linde B, Oelzner P, Katenkamp K, Hein G, Wolf G (2007) Fulminate liver failure in a 39-year-old female patient with leukocytosis, unclear fever, and arthralgic pain. Med Klin (Munich) 102:846–851CrossRef
13.
go back to reference Pouchot J, Sampalis JS, Beaudet F, Carette S, Décary F, Salusinsky-Sternbach M, Hill RO, Gutkowski A, Harth M, Myhal D et al (1991) Adult Still’s disease: manifestations, disease course, and outcome in 62 patients. Medicine (Baltimore) 70:118–136 Pouchot J, Sampalis JS, Beaudet F, Carette S, Décary F, Salusinsky-Sternbach M, Hill RO, Gutkowski A, Harth M, Myhal D et al (1991) Adult Still’s disease: manifestations, disease course, and outcome in 62 patients. Medicine (Baltimore) 70:118–136
14.
go back to reference Hellwig D, Graeter TP, Ukena D, Groeschel A, Sybrecht GW, Schaefers HJ, Kirsch CM (2007) 18F-FDG PET for mediastinal staging of lung cancer: which SUV threshold makes sense? J Nucl Med 48:1761–1766PubMedCrossRef Hellwig D, Graeter TP, Ukena D, Groeschel A, Sybrecht GW, Schaefers HJ, Kirsch CM (2007) 18F-FDG PET for mediastinal staging of lung cancer: which SUV threshold makes sense? J Nucl Med 48:1761–1766PubMedCrossRef
15.
go back to reference Komori T, Narabayashi I, Matsumura K, Matsuki M, Akagi H, Ogura Y, Aga F, Adachi I (2007) 2-[Fluorine-18]-fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography versus whole-body diffusion-weighted MRI for detection of malignant lesions: initial experience. Ann Nucl Med 21:209–215PubMedCrossRef Komori T, Narabayashi I, Matsumura K, Matsuki M, Akagi H, Ogura Y, Aga F, Adachi I (2007) 2-[Fluorine-18]-fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography versus whole-body diffusion-weighted MRI for detection of malignant lesions: initial experience. Ann Nucl Med 21:209–215PubMedCrossRef
16.
go back to reference Chen YK, Su CT, Chi KH, Cheng RH, Wang SC, Hsu CH (2007) Utility of 18F-FDG PET/CT uptake patterns in Waldeyer’s ring for differentiating benign from malignant lesions in lateral pharyngeal recess of nasopharynx. J Nucl Med 48:8–14PubMed Chen YK, Su CT, Chi KH, Cheng RH, Wang SC, Hsu CH (2007) Utility of 18F-FDG PET/CT uptake patterns in Waldeyer’s ring for differentiating benign from malignant lesions in lateral pharyngeal recess of nasopharynx. J Nucl Med 48:8–14PubMed
17.
go back to reference Jaffe ES, Ralfkiaer E (2001) Hepatosplenic T-cell lymphoma. In: Jaffe ES, Harris NL, Stein H et al (eds) World Health Organization classification of tumors: pathology and genetics of tumors of haematopoietic and lymphoid tissues. IARC Press, Lyon, pp 210–201 Jaffe ES, Ralfkiaer E (2001) Hepatosplenic T-cell lymphoma. In: Jaffe ES, Harris NL, Stein H et al (eds) World Health Organization classification of tumors: pathology and genetics of tumors of haematopoietic and lymphoid tissues. IARC Press, Lyon, pp 210–201
18.
go back to reference Weidmann E (2000) Hepatosplenic T-cell lymphoma. A review on 45 cases since the first report describing the disease as distinct lymphoma entity in 1990. Leukemia 14:991–997PubMedCrossRef Weidmann E (2000) Hepatosplenic T-cell lymphoma. A review on 45 cases since the first report describing the disease as distinct lymphoma entity in 1990. Leukemia 14:991–997PubMedCrossRef
19.
go back to reference Arlet JB, Le Thi Huong DB, Pouchot J, Piette JC (2005) Current oncepts on the physiopathology of adult-onset Still’s disease. Rev Med Interne 26:549–556PubMedCrossRef Arlet JB, Le Thi Huong DB, Pouchot J, Piette JC (2005) Current oncepts on the physiopathology of adult-onset Still’s disease. Rev Med Interne 26:549–556PubMedCrossRef
20.
go back to reference Hoshino T, Ohta A, Kawamoto M et al (1998) Elevated serum interleukin 6, interferon-gamma, and tumor necrosis factor-alpha levels in patients with adult Still’s disease. J Rheumatol 25:396–398PubMed Hoshino T, Ohta A, Kawamoto M et al (1998) Elevated serum interleukin 6, interferon-gamma, and tumor necrosis factor-alpha levels in patients with adult Still’s disease. J Rheumatol 25:396–398PubMed
21.
go back to reference Matsui K, Tsuchida T, Tominaga K et al (1999) High serum level of macrophage-colony stimulating factor(M-CSF) in adult onset Still’s disease. Rheumatology (Oxford) 38:477–478CrossRef Matsui K, Tsuchida T, Tominaga K et al (1999) High serum level of macrophage-colony stimulating factor(M-CSF) in adult onset Still’s disease. Rheumatology (Oxford) 38:477–478CrossRef
22.
go back to reference Nishida T, Suzuki K, Kuwada N, Nakamura Y, Motoyoshi K, Kamakura K (2001) Hemophagocytic syndrome and adult Still’s disease associated with meningoencephalitis and unconsciousness. Intern Med 40:1037–1040PubMedCrossRef Nishida T, Suzuki K, Kuwada N, Nakamura Y, Motoyoshi K, Kamakura K (2001) Hemophagocytic syndrome and adult Still’s disease associated with meningoencephalitis and unconsciousness. Intern Med 40:1037–1040PubMedCrossRef
23.
go back to reference Andrès E, Locatelli F, Pflumio F, Marcellin L (2001) Liver biopsy is not useful in the diagnosis of adult Still’s disease. Q J Med 94:568–569 Andrès E, Locatelli F, Pflumio F, Marcellin L (2001) Liver biopsy is not useful in the diagnosis of adult Still’s disease. Q J Med 94:568–569
Metadata
Title
A case of adult onset Still’s disease showing marked accumulation in the liver and spleen, on positron emission tomography–CT images
Authors
Masanori Funauchi
Shinya Ikoma
Kazuya Kishimoto
Hideki Shimazu
Yuji Nozaki
Masafumi Sugiyama
Koji Kinoshita
Publication date
01-08-2008
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 10/2008
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-008-0562-3

Other articles of this Issue 10/2008

Rheumatology International 10/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.